Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A135946-250mg | 250mg | In stock | $9.90 | |
A135946-1g | 1g | In stock | $19.90 | |
A135946-5g | 5g | In stock | $85.90 |
Potent, competitive, non-selective mAChR antagonist
Synonyms | (1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate | alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester | Atropine, >=95.0% (NT) | InChI=1/C11H8Cl2N2O/c12-8-1-2-9(10(13)5-8)11(16)6-15-4-3-14-7-15 |
---|---|
Specifications & Purity | 99% |
Storage Temp | Store at 2-8°C,Protected from light,Argon charged |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Muscarinic acetylcholine receptor M2 antagonist |
ALogP | 1.8 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate |
---|---|
INCHI | InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16? |
InChi Key | RKUNBYITZUJHSG-PJPHBNEVSA-N |
Canonical SMILES | CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 |
Isomeric SMILES | CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 |
WGK Germany | 3 |
RTECS | CK0700000 |
PubChem CID | 174174 |
Molecular Weight | 289.37 |
Beilstein | 91260 |
ChEBI | CHEBI:16684 |
---|---|
Wikipedia | Atropine |
DrugBank Ligand | DB00572 |
CAS Registry No. | 51-55-8 |
ChEMBL Ligand | CHEMBL517712 |
PubChem CID | 174174 |
PEP | atropine |
DrugCentral Ligand | 260 |
GPCRdb Ligand | atropine |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
L2307231 | Certificate of Analysis | Dec 12, 2023 | A135946 |
L2307239 | Certificate of Analysis | Dec 12, 2023 | A135946 |
L2307240 | Certificate of Analysis | Dec 12, 2023 | A135946 |
L2307241 | Certificate of Analysis | Dec 12, 2023 | A135946 |
L2307242 | Certificate of Analysis | Dec 12, 2023 | A135946 |
L2307243 | Certificate of Analysis | Dec 12, 2023 | A135946 |
K2301123 | Certificate of Analysis | Oct 21, 2023 | A135946 |
K2301125 | Certificate of Analysis | Oct 21, 2023 | A135946 |
K2301136 | Certificate of Analysis | Oct 21, 2023 | A135946 |
Solubility | Soluble in dilute aqueous acid, ethanol. |
---|---|
Sensitivity | Light & Air sensitive. |
Pictogram(s) | GHS06 |
---|---|
Signal | Danger |
Hazard Statements | H300+H330:Fatal if swallowed or if inhaled |
Precautionary Statements | P301+P310:IF SWALLOWED: Immediately call a POISON CENTER/doctor/... P310:Immediately call a POISON CENTER or doctor/physician. P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P284:[In case of inadequate ventilation] Wear respiratory protection. |
WGK Germany | 3 |
RTECS | CK0700000 |
Starting at $532.90
Starting at $285.90
Starting at $30.90
Starting at $241.90
Starting at $43.90
1. Dianfa Zhao, Jie Liu, Yunshan Zhou, Lijuan Zhang, Yuxu Zhong, Yang Yang, Baoquan Zhao, Mengru Yang, Yong’an Wang. (2023) Penetrating the Blood–Brain Barrier for Targeted Treatment of Neurotoxicant Poisoning by Nanosustained-Released 2-PAM@VB1-MIL-101-NH2(Fe). ACS Applied Materials & Interfaces, 15 (10): (12631–12642). [PMID:36867458] |
2. Dianfa Zhao, Jie Liu, Lijuan Zhang, Yunshan Zhou, Yuxu Zhong, Yang Yang, Chengcheng Huang, Yong’an Wang. (2022) Loading and Sustained Release of Pralidoxime Chloride from Swellable MIL-88B(Fe) and Its Therapeutic Performance on Mice Poisoned by Neurotoxic Agents. INORGANIC CHEMISTRY, 61 (3): (1512–1520). [PMID:34969248] |
1. Carr BJ, Mihara K, Ramachandran R, Saifeddine M, Nathanson NM, Stell WK, Hollenberg MD. (2018) Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.. Invest Ophthalmol Vis Sci, 59 (7): (2778-2791). [PMID:29860464] |
2. Radzicki D et al.. (2017) Loss of M1 Receptor Dependent Cholinergic Excitation Contributes to mPFC Deactivation in Neuropathic Pain.. J Neurosci, 37 (9): (2292-2304). [PMID:28137966] |
3. Huang H et al.. (2019) M1 Macrophage Activated by Notch Signal Pathway Contributed to Ventilator-Induced Lung Injury in Chronic Obstructive Pulmonary Disease Model.. J Surg Res, 244 (358-367). [PMID:31323391] |
4. Wang YJ et al.. (2017) The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.. Anesth Analg, 124 (4): (1330-1338). [PMID:28002166] |
5. Dianfa Zhao, Jie Liu, Yunshan Zhou, Lijuan Zhang, Yuxu Zhong, Yang Yang, Baoquan Zhao, Mengru Yang, Yong’an Wang. (2023) Penetrating the Blood–Brain Barrier for Targeted Treatment of Neurotoxicant Poisoning by Nanosustained-Released 2-PAM@VB1-MIL-101-NH2(Fe). ACS Applied Materials & Interfaces, 15 (10): (12631–12642). [PMID:36867458] |
6. Dianfa Zhao, Jie Liu, Lijuan Zhang, Yunshan Zhou, Yuxu Zhong, Yang Yang, Chengcheng Huang, Yong’an Wang. (2022) Loading and Sustained Release of Pralidoxime Chloride from Swellable MIL-88B(Fe) and Its Therapeutic Performance on Mice Poisoned by Neurotoxic Agents. INORGANIC CHEMISTRY, 61 (3): (1512–1520). [PMID:34969248] |